Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ainos Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AIMD
Over the counter
8731
http://www.ainos.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ainos Inc
Ainos Announces Positive Results from Preclinical Studies of Its Low-dose Oral Interferon Formulation Against COVID-19
- Jun 27th, 2022 11:00 am
Ainos COVID-19 Antigen Self-Test Receives Approval for Sale in Taiwan
- Jun 21st, 2022 11:00 am
Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection
- Dec 7th, 2021 11:55 pm
Ainos SRNA Research Initiative Announces Milestones for mRNA Vaccine Development
- Nov 3rd, 2021 4:00 pm
Ainos Elects Ms. Hui-Lan (Celia) Wu as CFO, Lawrence K. Lin as Executive Vice President of Operations, and Other Key Executives
- Aug 16th, 2021 1:23 pm
Scroll